Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome-Reference-Cited by-同舟云学术

Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome

Published:2018-08-01 Issue:8 Volume:4 Page:1085
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Chang Kyle¹²,Taggart Melissa W.³,Reyes-Uribe Laura¹,Borras Ester¹,Riquelme Erick¹,Barnett Reagan M.¹,Leoni Guido⁴,San Lucas F. Anthony⁵,Catanese Maria T.⁴,Mori Federica⁶,Diodoro Maria G.⁷,You Y. Nancy⁸⁹,Hawk Ernest T.¹,Roszik Jason¹⁰¹¹,Scheet Paul²⁵,Kopetz Scott¹²,Nicosia Alfredo⁴¹³¹⁴,Scarselli Elisa⁴,Lynch Patrick M.⁹¹⁵,McAllister Florencia¹²⁹¹²,Vilar Eduardo¹²⁹¹²

Affiliation:

1. Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston

2. Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston

3. Department of Pathology, University of Texas MD Anderson Cancer Center, Houston

4. Nouscom SRL, Rome, Italy

5. Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston

6. ReiThera SRL, Rome, Italy

7. Department of Pathology, “Regina Elena” National Cancer Institute, Rome, Italy

8. Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston

9. Clinical Cancer Genetics Program, University of Texas MD Anderson Cancer Center, Houston

10. Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston

11. Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston

12. Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston

13. CEINGE, Naples, Italy

14. Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy

15. Department of Gastroenterology, Hepatology and Nutrition, University of Texas MD Anderson Cancer Center, Houston

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Reference34 articles.

1. Molecular genetics of colorectal cancer.;Fearon;Annu Rev Pathol,2011

2. Milestones of Lynch syndrome: 1895-2015.;Lynch;Nat Rev Cancer,2015

3. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.;Bonadona;JAMA,2011

4. Precancer atlas to drive precision prevention trials.;Spira;Cancer Res,2017

5. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.;Järvinen;Gastroenterology,2000

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of PD-1 inhibitors for colorectal cancer and polyps in Lynch syndrome patients;European Journal of Cancer;2023-10

2. Advances in vaccine development for cancer prevention and treatment in Lynch Syndrome;Molecular Aspects of Medicine;2023-10

3. Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade;Nature Medicine;2023-10

4. Current Trends in Vaccine Development for Hereditary Colorectal Cancer Syndromes;Clinics in Colon and Rectal Surgery;2023-07-31

5. Immune escape and resistance to immunotherapy in mismatch repair deficient tumors;Frontiers in Immunology;2023-07-10